Stericycle Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/10/2024)
| Balance Sheet | Total Assets | 5,352,600,000.00 | ROE | – |
| Balance Sheet | Total Equity | 2,522,900,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -128,400,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 114,900,000.00 | – | – |
| Cashflow | Operating Cash Flow | 243,300,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -0.23 | Div. Yield | – |
| Income | Net Income | -21,400,000.00 | P/E | – |
| Income | Shares Outstanding | 92,400,000.00 | P/B | – |
| Income | Total Revenue | 2,677,600,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Stericycle, Inc., is in the business of managing regulated waste and providing an array of related and complementary services. The Company operates in the United States, Argentina, Brazil, Canada, Chile, Ireland, Japan, Mexico, Portugal, Romania, Spain, and the United Kingdom. The regulated waste services the Company provides include medical waste disposal, its Steri-Safe medical waste and compliance program, its Clinical Services program, its Bio Systems reusable sharps disposal management services, pharmaceutical waste disposal, and hazardous waste disposal. In addition to the Company's regulated waste services, the Company offers regulated recall and returns management services, patient communication services, and medical safety products. In August 2013, Stericycle Inc acquired Eclipse Marketing.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.stericycle.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more